Glycoprotein IIIa polymorphism and risk of myocardial infarction

Cardiovascular Research

Volumn 33, Issue 3, 1997, Pages 693-697

  Samani, Nilesh J ^a,b   Lodwick, David ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

DNA polymorphism; Genetics; Glycoprotein IIb IIIa; Human; Integrins; Myocardial infarction; Platelets

Indexed keywords

INTEGRIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR; THROMBOCYTE ADHESION;

ALLELES; GENOTYPE; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK;

EID: 0031052297     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00222-2     Document Type: Article

References (24)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. New Engl J Med 1992;326:242-250.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
3. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. New Engl J Med 1994;330:1041-1046.
4. Hegle RA, Huang L-S, Herbert PN, Blum CB, Buring JE, Hennekens CH, Breslow JL. Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction. New Engl J Med 1986;315:1509-1515.
5. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992;359:641-643.
6. Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans A, Samama MM, Cambien F. Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study. Arterioscl Thromb 1993; 13:886-891.
7. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;2:349-360.
8. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.
9. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New Engl J Med 1995;332:1553-1559.
10. The EPIC Investigators. Use of a monoclonal body directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. New Engl J Med 1994;330:956-961.
11. Heidenreich R, Eisman R, Surrey S, Delgrosso K, Bennett JS, Schwanz E, Poncz M. Organisation of the gene for platelet glycoprotein IIb. Biochemistry 1990;29:1232-1244.
12. Zimrin AB, Gidwitz S, Lord S, Schwartz E, Bennett JS, White GC III, Poncz M. The genomic organisation of platelet glycoprotein IIIa. J Biol Chem 1990;265:8590-8595.
13. Bray PF, Schuman MA. Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia. Blood 1990;75:881-888.
14. Burk CD, Newman PJ, Lyman S, Gill J, Coller BS, Poncz M. A deletion in the gene for glycoprotein IIb associated with Glanzmann's thrombasthenia. J Clin Invest 1991;87:270-276.
15. A2, are associated with a leucine33/proline 33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest 1989;83:1778-1781..
16. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. New Engl J Med 1996;334:1090-1094.
17. Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q J Med 1996;89:437-444.
18. WHO (Report of the Joint International Society and Federation of Cardiology/World Health Organisation Task Force on Standardization of Clinical Nomenclature). Nomenclature and criteria for diagnosis of ischaemic heart disease. Circulation 1979;59:607-609.
19. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989.
20. Jin Y, Dietz HC, Nurden A, Bray PF. Single-strand confirmation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood 1993;82:2281-2288.
21. McGill HC. Risk factors for coronary atherosclerosis. Adv Exp Med Biol 1978;104:273-280.
22. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-2048.
23. Kim HO, Jin Y, Kickler TS, Blakemore K, Kwon OH, Bray PF. Gene frequencies of the five major human platelet antigens in African American, white and Korean populations. Transfusion 1995;35:863-867.
24. Simsek S, Faber NM, Bleeker PM, Viekke ABJ, Huiskes E, Goldschmeding R, von dem Borne AEGKr. Determination of human platelet antigen frequencies in the Dutch population by immunophenotyping and DNA (allele-specific restriction enzyme) analysis. Blood 1993;81:835-840.